4,5 Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior weight loss and expanded therapeutic applications spanning from brain health to renal disease, Clarivate researchers noted
Research shows that when people stop using the medication, they can regain up to two-thirds of lost weight within a year
Can people with hypothyroidism take GLP-1 medications
Bringing this genetic and biomarker context to your endocrinology or primary care provider can support a more personalized decision-making process
L.FacinaA
Hakeshzadeh, F., Tabibi, H., Ahmadinejad, M., Malakoutian, T., and Hedayati, M